Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments

被引：19
|
作者：
Brugha, Rossa E. [4 ]
Davies, Jane C. [1 ,2 ,3 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Dept Paediat Resp Med, London SW3 6NP, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Gene Therapy, London SW3 6NP, England
[3] Royal Brompton & Harefield NHS Fdn Trust, London SW3 6NP, England
[4] Barts & London Queen Marys Sch Med & Dent, Ctr Paediat, Blizard Inst Cell & Mol Sci, London, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2011年 / 72卷 / 11期
关键词：
AIRWAY PSEUDOMONAS; INFECTIONS; EFFICACY; SURFACE; SAFETY;
D O I：
10.12968/hmed.2011.72.11.614
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pseudomonas aeruginosa is the most problematic organism in patients with cystic fibrosis. This article reviews its pathogenic mechanisms, with particular relevance to the pathophysiology of the cystic fibrosis airway, and recent advances in therapeutic approaches.
引用
收藏
页码：614 / 619
页数：6
相关论文
共 50 条
  • [31] MICROEVOLUTION OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS LUNGS
    Cramer, N.
    Klockgether, J.
    Davenport, C. F.
    Tuemmler, B.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 324 - 324
  • [32] Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
    Döring, G
    Taccetti, G
    Campana, S
    Festini, F
    Mascherini, M
    EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) : 653 - 653
  • [33] Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics
    Schmid, J.
    Ling, L. J.
    Leung, J. L. S.
    Zhang, H.
    Kolbe, J.
    Wesley, A. W.
    Mills, G. D.
    Brown, P. J.
    Jones, D. T.
    Laing, R. T. R.
    Pattemore, P. K.
    Taylor, D. R.
    Grimwood, K.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (06) : 1583 - 1590
  • [34] Pseudomonas aeruginosa and the Biofilm in People with Cystic Fibrosis
    Cohen-Cymberknoh, Malena
    PEDIATRIC PULMONOLOGY, 2023, 58 : S63 - S63
  • [35] CYSTIC-FIBROSIS AND PSEUDOMONAS-AERUGINOSA
    PIER, GB
    BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (03) : 222 - 222
  • [36] MICROEVOLUTION OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS LUNGS
    Klockgether, J.
    Cramer, N.
    Fischer, S.
    Dorda, M.
    Wiehlmann, L.
    Tummler, B.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S337 - S337
  • [37] New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
    Waters, Valerie
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) : 696 - 725
  • [38] ROLE OF ADHERENCE IN THE PATHOGENESIS OF PSEUDOMONAS-AERUGINOSA LUNG INFECTION IN CYSTIC-FIBROSIS PATIENTS
    WOODS, DE
    BASS, JA
    JOHANSON, WG
    STRAUS, DC
    INFECTION AND IMMUNITY, 1980, 30 (03) : 694 - 699
  • [39] The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: More questions than answers
    Kerem, E
    PEDIATRIC PULMONOLOGY, 1997, : 265 - 266
  • [40] ENVIRONMENTAL SENSORY SIGNALS AND MICROBIAL PATHOGENESIS - PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS
    DEVAULT, JD
    BERRY, A
    MISRA, TK
    DARZINS, A
    CHAKRABARTY, AM
    BIO-TECHNOLOGY, 1989, 7 (04): : 352 - 357
12345